Shire Plc CEO Discusses Q4 2010 Results - Earnings Call Transcript

Shire plc (SHPGY)

Q4 2010 Earnings Call

February 10, 2011 9:00 am ET

Executives

Eric Rojas - Director, North America Investor Relations

Angus Russell - Chief Executive Officer

Graham Hetherington - Chief Financial Office

Mike Cola - President, Specialty Pharmaceuticals

Sylvie Grégoire - President, Human Genetic Therapies

Analysts

Ken Cacciatore - Cowen and Company, LLC.

Peter Verdult - Morgan Stanley Dean Witter

David Buck - Buckingham Research Group

Kerry Holford - Credit Suisse

David Steinberg - Deutsche Bank Securities Inc.

Graham Parry - Merrill Lynch

Brian Bourdot - Barclays Capital

Frank Pinkerton - SunTrust Robinson Humphrey

Presentation

Operator

Compare to:
Previous Statements by SHPGY
» Shire Plc. CEO Discusses Q3 2010 Results - Earnings Call Transcript
» Shire Plc. Q2 2010 Earnings Call Transcript
» Shire plc Q4 2009 Earnings Call Transcript
» Shire plc Q3 2009 Earnings Call Transcript

A very good day to you, ladies and gentlemen. Welcome to the Shire 2010 Full-Year Results Conference Call hosted by Angus Russell. My name is Nancy, I'm the operator for the call today. Your lines will remain on listen-only throughout the conference. (Operator Instructions) I'd like to advice all parties this call is being recorded for replay purposes.

I would now like to hand the call over to Eric Rojas. Please go ahead.

Eric Rojas

Thanks, Nancy. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's full-year 2010 financial results. By now you should have all received our press release and should be viewing our presentation via our website on shire.com. If for some reasons you have not received the press release or are unable to access our website, please contact Souheil Salah in our UK Investor Relations Department on [phone] and he will be happy to assist you.

1 2 3 4 5 Next › Last »